Jim Glasheen
Fondatore presso Clade Therapeutics, Inc.
Posizioni attive di Jim Glasheen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Presidente | - | - | |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Investitore di Private Equity | - | - |
First Citizens Bank Ltd.
First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jim Glasheen
Precedenti posizioni note di Jim Glasheen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Direttore/Membro del Consiglio | 01/01/2018 | 31/12/2020 |
Amministratore Delegato | 01/01/2018 | 31/12/2020 | |
Fondatore | 01/01/2018 | 31/12/2020 | |
Presidente | 01/01/2018 | 31/12/2020 |
Formazione di Jim Glasheen
Duke University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Trinidad e Tobago | 2 |
Posizioni
Director/Board Member | 3 |
Founder | 2 |
President | 2 |
Settori
Finance | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Finance |
First Citizens Bank Ltd.
First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Finance |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Jim Glasheen
- Esperienza